691P Mechanisms of Acquired Resistance to First-Line (1L) Osimertinib in EGFR-mutated (egfrm) Advanced NSCLC: Results from a Prospective, Multi-Center, Real-World Study in China (FLOURISH Study)
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要